Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset.

Literature DB >> 24423221

The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset.

Joann T Tschanz¹, Maria C Norton, Peter P Zandi, Constantine G Lyketsos.

Abstract

The Cache County Study on Memory in Aging is a longitudinal, population-based study of Alzheimer's disease (AD) and other dementias. Initiated in 1995 and extending to 2013, the study has followed over 5,000 elderly residents of Cache County, Utah (USA) for over twelve years. Achieving a 90% participation rate at enrolment, and spawning two ancillary projects, the study has contributed to the literature on genetic, psychosocial and environmental risk factors for AD, late-life cognitive decline, and the clinical progression of dementia after its onset. This paper describes the major study contributions to the literature on AD and dementia.

Entities: Chemical Disease Gene Species

Mesh：

Year: 2013 PMID： 24423221 PMCID： PMC4089882 DOI： 10.3109/09540261.2013.849663

Source DB: PubMed Journal: Int Rev Psychiatry ISSN： 0954-0261

139 in total

1. Midlife blood pressure and dementia: the Honolulu-Asia aging study.

Authors: L J Launer; G W Ross; H Petrovitch; K Masaki; D Foley; L R White; R J Havlik
Journal: Neurobiol Aging Date: 2000 Jan-Feb Impact factor: 4.673

2. Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib.

Authors: Barbara K Martin; Christine Szekely; Jason Brandt; Steven Piantadosi; John C S Breitner; Suzanne Craft; Denis Evans; Robert Green; Michael Mullan
Journal: Arch Neurol Date: 2008-05-12

3. Neuropsychiatric symptoms as risk factors for progression from CIND to dementia: the Cache County Study.

Authors: M E Peters; P B Rosenberg; M Steinberg; M C Norton; K A Welsh-Bohmer; K M Hayden; J Breitner; J T Tschanz; C G Lyketsos
Journal: Am J Geriatr Psychiatry Date: 2013-02-06 Impact factor: 4.105

4. Dementia incidence may increase more slowly after age 90: results from the Bronx Aging Study.

Authors: C B Hall; J Verghese; M Sliwinski; Z Chen; M Katz; C Derby; R B Lipton
Journal: Neurology Date: 2005-09-27 Impact factor: 9.910

5. Early-life risk factors and the development of Alzheimer's disease.

Authors: V M Moceri; W A Kukull; I Emanuel; G van Belle; E B Larson
Journal: Neurology Date: 2000-01-25 Impact factor: 9.910

6. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study.

Authors: Françoise Forette; Marie-Laure Seux; Jan A Staessen; Lutgarde Thijs; Marija-Ruta Babarskiene; Speranta Babeanu; Alfredo Bossini; Robert Fagard; Blas Gil-Extremera; Tovio Laks; Zhanna Kobalava; Cinzia Sarti; Jaakko Tuomilehto; Hannu Vanhanen; John Webster; Yair Yodfat; Willem H Birkenhäger
Journal: Arch Intern Med Date: 2002-10-14

7. Incidence of dementia in mild cognitive impairment in the cardiovascular health study cognition study.

Authors: Oscar L Lopez; Lewis H Kuller; James T Becker; Corinne Dulberg; Robert A Sweet; H Michael Gach; Steven T Dekosky
Journal: Arch Neurol Date: 2007-03

8. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.

Authors: Peter P Zandi; James C Anthony; Ara S Khachaturian; Stephanie V Stone; Deborah Gustafson; JoAnn T Tschanz; Maria C Norton; Kathleen A Welsh-Bohmer; John C S Breitner
Journal: Arch Neurol Date: 2004-01

9. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial.

Authors: C G Lyketsos; J C S Breitner; R C Green; B K Martin; C Meinert; S Piantadosi; M Sabbagh
Journal: Neurology Date: 2007-04-25 Impact factor: 9.910

10. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors: L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal: JAMA Date: 1997 Oct 22-29 Impact factor: 56.272

18 in total

1. Methodology and preliminary results from the neurobiology of late-life depression study.

Authors: David C Steffens; Kevin J Manning; Rong Wu; James J Grady; Richard H Fortinsky; Howard A Tennen
Journal: Int Psychogeriatr Date: 2015-09-01 Impact factor: 3.878

2. Influence of Perceived Stress on Incident Amnestic Mild Cognitive Impairment: Results From the Einstein Aging Study.

Authors: Mindy J Katz; Carol A Derby; Cuiling Wang; Martin J Sliwinski; Ali Ezzati; Molly E Zimmerman; Jessica L Zwerling; Richard B Lipton
Journal: Alzheimer Dis Assoc Disord Date: 2016 Apr-Jun Impact factor: 2.703

Review 3. Sex Hormones and Cognition: Where Do We Stand?

Authors: Satish V Khadilkar; Varsha A Patil
Journal: J Obstet Gynaecol India Date: 2019-04-10

4. MRI Clinical Ratings and Cognitive Function in a Cross-Sectional Population Study of Dementia: The Cache County Memory Study.

Authors: Y H W Tsui-Caldwell; T J Farrer; Z McDonnell; Z Christensen; C Finuf; E D Bigler; J T Tschanz; M C Norton; K A Welsh-Bohmer
Journal: J Prev Alzheimers Dis Date: 2019

5. Death of family members as an overlooked source of racial disadvantage in the United States.

Authors: Debra Umberson; Julie Skalamera Olson; Robert Crosnoe; Hui Liu; Tetyana Pudrovska; Rachel Donnelly
Journal: Proc Natl Acad Sci U S A Date: 2017-01-23 Impact factor: 11.205

Review 6. Cannabinoids for the treatment of dementia.

Authors: Dina Bosnjak Kuharic; Domagoj Markovic; Tonci Brkovic; Milka Jeric Kegalj; Zana Rubic; Ana Vuica Vukasovic; Ana Jeroncic; Livia Puljak
Journal: Cochrane Database Syst Rev Date: 2021-09-17

7. Prevalence and correlates of subjective memory complaints in Vietnamese adults.

Authors: Oanh L Meyer; Amanda Leggett; Siwei Liu; Ngoc H Nguyen
Journal: Int Psychogeriatr Date: 2017-12-04 Impact factor: 3.878

8. Improving hearing and vision in dementia: protocol for a field trial of a new intervention.

Authors: Jemma Regan; Piers Dawes; Annie Pye; Christopher J Armitage; Mark Hann; Ines Himmelsbach; David Reeves; Zoe Simkin; Fan Yang; Iracema Leroi
Journal: BMJ Open Date: 2017-11-28 Impact factor: 2.692

9. Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease.

Authors: Jacob W Vogel; Etienne Vachon-Presseau; Alexa Pichet Binette; Angela Tam; Pierre Orban; Renaud La Joie; Mélissa Savard; Cynthia Picard; Judes Poirier; Pierre Bellec; John C S Breitner; Sylvia Villeneuve
Journal: Brain Date: 2018-06-01 Impact factor: 15.255

10. Underrepresentation of African-Americans in Alzheimer's Trials: A Call for Affirmative Action.

Authors: Jaewook Shin; P Murali Doraiswamy
Journal: Front Aging Neurosci Date: 2016-06-03 Impact factor: 5.750